HighTower Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

HighTower Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.97M	Buy	20,053 +255	+1%	+$54.9K	﹤0.01%	1253
2026 Q1	$3.98M	Buy	19,798 +89	+0.5%	+$18.4K	﹤0.01%	1323
2025 Q4	$4.07M	Buy	19,709 +882	+5%	+$176K	﹤0.01%	1270
2025 Q3	$3.38M	Buy	18,827 +552	+3%	+$94K	﹤0.01%	1339
2025 Q2	$2.95M	Buy	18,275 +3,645	+25%	+$581K	﹤0.01%	1359
2025 Q1	$2.49M	Buy	14,630 +1,928	+15%	+$335K	﹤0.01%	1411
2024 Q4	$2.11M	Sell	12,702 -3,658	-22%	-$625K	﹤0.01%	1488
2024 Q3	$2.82M	Buy	16,360 +156	+1%	+$25.8K	﹤0.01%	1308
2024 Q2	$2.49M	Buy	+16,204	New	+$2.43M	﹤0.01%	1332
2024 Q1	–	Sell	-16,909	Closed	-$2.68M	–	3742
2023 Q4	$2.68M	Sell	16,909 -1,618	-9%	-$232K	﹤0.01%	1278
2023 Q3	$2.72M	Buy	+18,527	New	+$2.82M	0.01%	1215
2021 Q2	–	Sell	-25,328	Closed	-$4.05M	–	3230
2021 Q1	$4.05M	Buy	+25,328	New	+$4.34M	0.01%	822
2019 Q4	–	Sell	-13,264	Closed	-$1.65M	–	2435
2019 Q3	$1.65M	Sell	13,264 -16,901	-56%	-$2.25M	0.01%	952
2019 Q2	$4.25M	Buy	30,165 +8,884	+42%	+$1.23M	0.03%	614
2019 Q1	$3.21M	Sell	21,281 -1,879	-8%	-$270K	0.02%	670
2018 Q4	$2.87M	Buy	23,160 +18,681	+417%	+$2.55M	0.02%	627
2018 Q3	$705K	Buy	4,479 +772	+21%	+$117K	0.01%	1291
2018 Q2	$524K	Buy	3,707 +1,207	+48%	+$166K	﹤0.01%	1422
2018 Q1	$334K	Buy	+2,500	New	+$341K	﹤0.01%	1630
2017 Q1	–	Sell	-15,594	Closed	-$1.42M	–	2112
2016 Q4	$1.42M	Buy	+15,594	New	+$1.46M	0.02%	831
2016 Q2	–	Sell	-9,581	Closed	-$839K	–	1854
2016 Q1	$839K	Sell	9,581 -24,721	-72%	-$2.18M	﹤0.01%	1125
2015 Q4	$3.88M	Buy	+34,302	New	+$3.69M	0.05%	398
2015 Q3	–	Sell	-52,389	Closed	-$6.5M	–	1890
2015 Q2	$6.5M	Buy	52,389 +14,772	+39%	+$1.78M	0.1%	213
2015 Q1	$4.45M	Buy	37,617 +1,851	+5%	+$209K	0.07%	327
2014 Q4	$3.65M	Buy	35,766 +585	+2%	+$57.1K	0.06%	371
2014 Q3	$3.23M	Sell	35,181 -4,506	-11%	-$391K	0.05%	377
2014 Q2	$3.27M	Buy	+39,687	New	+$3.03M	0.06%	377

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

HighTower Advisors's FBT Position: Q2 2026 in Review

HighTower Advisors increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1.3% in Q2 2026, buying an estimated $54.9K and bringing the position to 20,053 shares worth $4.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

HighTower Advisors first reported a position in FBT in Q2 2014 and has held it in 27 quarters since. The position peaked at $6.5M in Q2 2015. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

HighTower Advisors held 20,053 shares of First Trust NYSE Arca Biotechnology Index Fund worth $4.97M as of Q2 2026.
HighTower Advisors bought 255 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $54.9K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1253 holding.
HighTower Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2014 and has held it in 27 quarters since.
HighTower Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $6.5M in Q2 2015.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.